TABLE 1.
Baseline demographic characteristics
| Treatment group (n) | Mean age ± SD (yr), range | Race (no. [%] African/Caucasian/Hispanic) | Mean ht ± SD (cm), range | Mean wt ± SD (kg), range | Mean BMI ± SD (kg/m2), range |
|---|---|---|---|---|---|
| Placebo (8) | 30.4 ± 8.9 (20-46) | 4/4/0 (50/50/0) | 181.3 ± 6.9 (170.2-193.0) | 89.3 ± 16.0 (59.1-108.6) | 27.0 ± 3.7 (19.2-30.0) |
| BVM, 25 mg (6) | 33.3 ± 11.0 (18-46) | 3/2/1 (50/33/16.7) | 176.1 ± 8.5 (165.1-188.0) | 87.0 ± 10.2 (69.1-99.5) | 28.1 ± 2.7 (24.1-30.0) |
| BVM, 50 mg (6) | 29.5 ± 14.6 (19-54) | 0/5/1 (0/83.3/16.7) | 174.8 ± 6.5 (170.2-185.4) | 84.1 ± 7.0 (78.6-95.0) | 27.6 ± 2.6 (22.9-30.2) |
| BVM, 100 mg (6) | 31.0 ± 12.9 (20-49) | 1/5/0 (16.7/83.3/0) | 177.0 ± 8.3 (162.6-185.4) | 77.7 ± 10.6 (60.9-91.4) | 24.8 ± 3.0 (21.7-28.9) |
| BVM, 250 mg (6) | 33.8 ± 9.2 (20-43) | 3/3/0 (50/50/0) | 174.8 ± 5.7 (167.6-182.9) | 77.8 ± 13.5 (64.1-96.4) | 25.3 ± 3.8 (20.3-30.5) |
| Total (32) | 31.5 ± 10.7 (18-54) | 11/19/2 (34.4/59.4/6.3) | 177.1 ± 7.2 (162.6-193.0) | 83.5 ± 12.4 (59.1-108.6) | 26.6 ± 3.3 (19.2-30.5) |